Skip to main content

Analysis of an SIS epidemic model with treatment

Abstract

An SIS epidemic model with saturated incidence rate and treatment is considered. According to different recovery rates, we use differential stability theory and qualitative theory to analyze the various kinds of endemic equilibria and disease-free equilibrium. Finally, we get complete configurations of different endemic equilibria and disease-free equilibrium.

1 Introduction and model

Infectious diseases have tremendous influence on human life and will bring huge panic and disaster to mankind once out of control. Every year millions of human beings suffer from or die of various infectious diseases. In order to predict the spreading of infectious diseases, many epidemic models have been proposed and analyzed in recent years (see [113]). Some new conditions should be considered into SIS model to extend the results.

Li et al. (see [13]) studied an SIS model with bilinear incidence rate βSI and treatment. The model takes into account the medical conditions. The recovery of the infected rate is divided into natural and unnatural recovery rates. Because of the medical conditions, when the number of infected persons reaches a certain amount I 0 , the unnatural recovery rate will be a fixed value δ I 0 . The study of this model should be divided into two cases to discuss with I I 0 and I> I 0 . In this paper, we study an SIS model with saturated incidence rate β S I 1 + α S and treatment, and we extend some recent results.

By a saturated incidence rate β S I 1 + α S , we consider an SIS epidemic model which consists of the susceptible individuals S(t), the infectious individuals I(t) and the total population N(t) at time t:

{ d S d t = A d S β S I 1 + α S + γ I + T ( I ) , d I d t = β S I 1 + α S ( d + ε + γ ) I T ( I ) , N ( t ) = S ( t ) + I ( t ) ,
(1.1)

where T(I)= { δ I , if  0 I I 0 , k , if  I I 0 (k=δ I 0 ) is the rate at which infected individuals are treated; A is the recruitment rate of individuals (including newborns and immigrants) into the susceptible population; β S I 1 + α S is the nonlinear incidence rate; d is the natural death rate; γ is the rate at which infected individuals are recovered; ε is the disease-related death rate, A, d, γ, δ, ε, α are all positive numbers.

Thus, if 0I I 0 , model (1.1) implies

{ d S d t = A d S β S I 1 + α S + γ I + δ I , d I d t = β S I 1 + α S ( d + ε + γ ) I δ I .
(1.2)

If I> I 0 , model (1.1) implies

{ d S d t = A d S β S I 1 + α S + γ I + k , d I d t = β S I 1 + α S ( d + ε + γ ) I k .
(1.3)

2 Existence of equilibria

Now, we study equilibria of model (1.1). Steady states of model (1.1) satisfy the following equations:

{ A d S β S I 1 + α S + γ I + T ( I ) = 0 , β S I 1 + α S ( d + ε + γ ) I T ( I ) = 0 .
(2.1)

We easily see that model (1.1) has a disease-free equilibrium P 0 ( A d ,0).

If 0<I I 0 , it follows from equation (2.1) that

{ A d S β S I 1 + α S + γ I + δ I = 0 , β S I 1 + α S ( d + ε + γ ) I δ I = 0 ,
(2.2)

and if I> I 0 , we get

{ A d S β S I 1 + α S + γ I + k = 0 , β S I 1 + α S ( d + ε + γ ) I k = 0 .
(2.3)

From two equations of (2.2), we have

S= A ( d + ε ) I d .
(2.4)

By substituting (2.4) into the second equation of (2.2), we obtain the following equations:

β A β ( d + ε ) I d + A α α ( d + ε ) I ( d + ε + γ + δ ) = 0 , ( d + ε ) [ β + α ( d + ε + γ + δ ) ] I = ( d + A α ) ( d + ε + γ + δ ) β A .
(2.5)

Let R 0 = β A ( d + A α ) ( d + ε + γ + δ ) . We study equation (2.5) as follows.

If α(d+ε+γ+δ)>β, R 0 <1 holds if and only if

I= ( d + A α ) ( d + ε + γ + δ ) ( 1 R 0 ) ( d + ε ) [ β + α ( d + ε + γ + δ ) ] >0

with

S= 1 d [ A ( d + ε ) ( d + A α ) ( d + ε + γ + δ ) ( 1 R 0 ) ( d + ε ) [ β + α ( d + ε + γ + δ ) ] ] = d + ε + γ + δ β + α ( d + ε + γ + δ ) <0.

So this case need not be considered.

If α(d+ε+γ+δ)<β, R 0 >1 holds if and only if

I= ( d + A α ) ( d + ε + γ + δ ) ( R 0 1 ) ( d + ε ) [ β α ( d + ε + γ + δ ) ] >0

with

S= d + ε + γ + δ β α ( d + ε + γ + δ ) >0.

Then we get a positive equilibrium P ( S , I ) of (1.2), where

I = ( d + A α ) ( d + ε + γ + δ ) ( R 0 1 ) ( d + ε ) [ β α ( d + ε + γ + δ ) ] , S = d + ε + γ + δ β α ( d + ε + γ + δ ) .

Furthermore, if 0< I I 0 , P ( S , I ) is an endemic equilibrium of model (1.1) when

1< R 0 1+ ( d + ε ) [ β α ( d + ε + γ + δ ) ] ( d + A α ) ( d + ε + γ + δ ) I 0 .

Define

n 0 =1+ ( d + ε ) [ β α ( d + ε + γ + δ ) ] ( d + A α ) ( d + ε + γ + δ ) I 0 .

Therefore model (1.1) has a disease-free equilibrium P 0 ( A d ,0) and has an endemic equilibrium P ( S , I ) except the disease-free equilibrium P 0 ( A d ,0) when 1< R 0 n 0 .

By substituting (2.4) into the second equation of (2.3), we obtain the following equation:

(d+ε) [ β α ( d + ε + γ ) ] I 2 + [ ( A α + d ) ( d + ε + γ ) β A k α ( d + ε ) ] I+k(Aα+d)=0.
(2.6)

Let b=(Aα+d)(d+ε+γ)βAkα(d+ε). We study equation (2.6) as follows.

If β=α(d+ε+γ), (2.6) has a positive root if b<0, then

I = k ( A α + d ) k α ( d + ε ) d ( d + ε + γ ) , S = k ( d + ε ) + A ( d + ε + γ ) k α ( d + ε ) d ( d + ε + γ ) < 0 .

So this case need not be considered.

If β<α(d+ε+γ), it follows from (2.6) that

(d+ε) [ α ( d + ε + γ ) β ] I 2 + [ β A + k α ( d + ε ) ( A α + d ) ( d + ε + γ ) ] Ik(Aα+d)=0.
(2.7)

Then

Δ 1 = [ β A + k α ( d + ε ) ( A α + d ) ( d + ε + γ ) ] 2 +4k(d+ε) [ α ( d + ε + γ ) β ] (Aα+d)>0.

Denoting two roots of (2.7) by I 1 and I 2 , we have

I 1 + I 2 = β A + k α ( d + ε ) ( A α + d ) ( d + ε + γ ) ( d + ε ) [ α ( d + ε + γ ) β ] , I 1 I 2 = k ( A α + d ) ( d + ε ) [ α ( d + ε + γ ) β ] < 0 .

So (2.7) has only one positive root, denote it by I 1 ,

I 1 = b + Δ 1 2 ( d + ε ) [ α ( d + ε + γ ) β ] , S 1 = 1 d [ A ( d + ε ) I 1 ] .

Then S 1 >0 holds only if

R 0 < ( A α d ) ( d + ε + γ ) + k α ( d + ε ) Δ 1 ( A α + d ) ( d + ε + γ + δ ) .

Define

n 1 = ( A α d ) ( d + ε + γ ) + k α ( d + ε ) Δ 1 ( A α + d ) ( d + ε + γ + δ ) .

The point P 1 ( S 1 , I 1 ) satisfies (2.3), then I 1 > I 0 , i.e.,

b + Δ 1 2 ( d + ε ) [ α ( d + ε + γ ) β ] > I 0 ,

we have

Δ 1 >b+2(d+ε) [ α ( d + ε + γ ) β ] I 0 .
(2.8)

Then b+2(d+ε)[α(d+ε+γ)β] I 0 <0.

And

R 0 <1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + γ + δ ) 2 ( d + ε ) [ α ( d + ε + γ ) β ] I 0 ( d + ε + γ + δ ) ( A α + d ) .

Define

n 2 =1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + γ + δ ) 2 ( d + ε ) [ α ( d + ε + γ ) β ] I 0 ( d + ε + γ + δ ) ( A α + d ) .

Then (2.8) holds only if

{ b + 2 ( d + ε ) [ α ( d + ε + γ ) β ] I 0 0 , Δ 1 { b + 2 ( d + ε ) [ α ( d + ε + γ ) β ] I 0 } 2 .

Then

n 2 < R 0 1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + γ + δ ) + k ( d + ε + γ + δ ) I 0 + ( d + ε ) [ β α ( d + ε + γ ) ] I 0 ( A α + d ) ( d + ε + γ + δ ) ,

define

n 3 =1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + γ + δ ) + k ( d + ε + γ + δ ) I 0 + ( d + ε ) [ β α ( d + ε + γ ) ] I 0 ( A α + d ) ( d + ε + γ + δ ) .

So, if R 0 n 3 and R 0 n 1 , P 1 ( S 1 , I 1 ) is an endemic equilibrium, where

I 1 = b + Δ 1 2 ( d + ε ) [ α ( d + ε + γ ) β ] , S 1 = 1 d [ A ( d + ε ) I 1 ] .

If β>α(d+ε+γ), it is easy to see that (2.6) has no positive root if b0.

If b<0,

Δ 2 = b 2 4 k ( d + ε ) ( A α + d ) [ β α ( d + ε + γ ) ] , b = R 0 ( d + ε + γ + δ ) ( A α + d ) + ( A α + d ) ( d + ε + δ + γ ) k α ( d + ε ) δ ( A α + d ) .

Then Δ 2 0 implies b 2 4k(d+ε)(Aα+d)[βα(d+ε+γ)], we get

R 0 1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) 2 k ( A α + d ) ( d + ε ) [ β α ( d + ε + γ ) ] ( A α + d ) ( d + ε + δ + γ )

or

R 0 1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) + 2 k ( A α + d ) ( d + ε ) [ β α ( d + ε + γ ) ] ( A α + d ) ( d + ε + δ + γ ) .

Define

n 4 = 1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) 2 k ( A α + d ) ( d + ε ) [ β α ( d + ε + γ ) ] ( A α + d ) ( d + ε + δ + γ ) , n 5 = 1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) + 2 k ( A α + d ) ( d + ε ) [ β α ( d + ε + γ ) ] ( A α + d ) ( d + ε + δ + γ ) .

At the same time, b<0 holds if and only if R 0 >1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) .

Define

n 6 =1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) .

Therefore, if R 0 n 5 , we have b<0 and Δ 2 0, then (2.6) has two positive roots I 2 , I 3 , where

I 2 = b Δ 2 2 ( d + ε ) [ β α ( d + ε + γ ) ] , I 3 = b + Δ 2 2 ( d + ε ) [ β α ( d + ε + γ ) ] .

Then S i = 1 d [A(d+ε) I i ]>0 (i=2,3) holds only if

R 0 < 1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) + 2 A [ β α ( d + ε + γ ) ] + Δ 2 ( A α + d ) ( d + ε + δ + γ ) , R 0 < 1 δ ( A α + d ) + k α ( d + ε ) + Δ 2 ( A α + d ) ( d + ε + δ + γ ) + 2 A [ β α ( d + ε + γ ) ] ( A α + d ) ( d + ε + δ + γ ) .

Define

n 7 = 1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) + 2 A [ β α ( d + ε + γ ) ] + Δ 2 ( A α + d ) ( d + ε + δ + γ ) , n 8 = 1 δ ( A α + d ) + k α ( d + ε ) + Δ 2 ( A α + d ) ( d + ε + δ + γ ) + 2 A [ β α ( d + ε + γ ) ] ( A α + d ) ( d + ε + δ + γ ) .

It is easy to see that n 8 < n 7 , which implies that (2.6) has two positive equilibrium points P 2 ( S 2 , I 2 ), P 3 ( S 3 , I 3 ) if R 0 < n 8 , (2.6) has only one positive equilibrium point P 2 ( S 2 , I 2 ) if n 8 < R 0 < n 7 , (2.6) has no positive equilibrium point if R 0 n 7 .

Now, we consider the conditions for I i > I 0 (i=2,3).

I 2 > I 0 b Δ 2 > 2 ( d + ε ) [ β α ( d + ε + γ ) ] I 0 b + 2 ( d + ε ) [ β α ( d + ε + γ ) ] I 0 < 0 .

Then

R 0 >1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) + 2 ( d + ε ) [ β α ( d + ε + γ ) ] I 0 ( A α + d ) ( d + ε + δ + γ ) .

Define

n 9 =1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) + 2 ( d + ε ) [ β α ( d + ε + γ ) ] I 0 ( A α + d ) ( d + ε + δ + γ ) .

Furthermore,

b Δ 2 >2(d+ε) [ β α ( d + ε + γ ) ] I 0 { b + 2 ( d + ε ) [ β α ( d + ε + γ ) ] I 0 } 2 >Δ,

i.e.,

R 0 <1 δ ( A α + d ) + k α ( d + ε ) ( A α + d ) ( d + ε + δ + γ ) + k ( d + ε + δ + γ ) I 0 + ( d + ε ) [ β α ( d + ε + γ ) ] I 0 ( A α + d ) ( d + ε + δ + γ ) .

Therefore, if n 9 < R 0 < n 3 , I 2 > I 0 holds.

Similarly, if I 3 > I 0 ,

b+2(d+ε) [ β α ( d + ε + γ ) ] I 0 0

or

{ b + 2 ( d + ε ) [ β α ( d + ε + γ ) ] I 0 > 0 , Δ > { 2 ( d + ε ) [ β α ( d + ε + γ ) ] I 0 + b } 2 ,

we get R 0 n 9 or R 0 >max( n 3 , n 9 ).

From the above discussion, we get the following conclusions.

Theorem 2.1 If R 0 <1, model (1.2) has only one disease-free equilibrium P 0 ( A d ,0); if R 0 >1, model (1.2) has a unique endemic equilibrium P ( S , I ) except the disease-free equilibrium P 0 ( A d ,0); if 1< R 0 < n 0 , P ( S , I ) is a unique endemic equilibrium of model (1.1).

Theorem 2.2 If β<α(d+ε+γ), then P 1 ( S 1 , I 1 ) is a unique endemic equilibrium of model (1.3) if R 0 n 1 ; P 1 ( S 1 , I 1 ) is a unique endemic equilibrium of model (1.1) if R 0 n 1 and R 0 n 2 .

If β>α(d+ε+γ), model (1.3) has two positive equilibrium points P 2 ( S 2 , I 2 ), P 3 ( S 3 , I 3 ) if R 0 < n 8 ; model (1.3) has only one positive equilibrium point P 2 ( S 2 , I 2 ) if n 8 < R 0 < n 7 ; model (1.3) has no positive point if R 0 n 7 ; P 2 ( S 2 , I 2 ) is an endemic equilibrium of model (1.1) if n 9 < R 0 < n 3 ; P 3 ( S 3 , I 3 ) is an endemic equilibrium of model (1.1) if R 0 < n 9 or n 9 < R 0 < n 3 .

If β=α(d+ε+γ), model (1.3) has no endemic equilibrium.

3 Stability of equilibria

Theorem 3.1 The disease-free equilibrium P 0 ( A d ,0) is stable if R 0 <1 and is a saddle point if R 0 >1; the endemic equilibrium P ( S , I ) is a stable node if it exists; the endemic equilibrium P 1 ( S 1 , I 1 ) is a stable node if it exists; if the endemic equilibrium points P 2 ( S 2 , I 2 ), P 3 ( S 3 , I 3 ) exist, then P 2 ( S 2 , I 2 ) is a stable node of model (1.1) if b Δ 2 2 ( d + α ) [ β α ( d + α + γ ) ] D 1 + D 2 >0 and P 3 ( S 3 , I 3 ) is a stable node of model (1.1) if b + Δ 2 2 ( d + α ) [ β α ( d + α + γ ) ] D 1 + D 2 >0.

Proof The Jacobi matrix of model (1.2) is

J= [ d β I ( 1 + α S ) 2 β S 1 + α S + δ + γ β I ( 1 + α S ) 2 β S 1 + α S ( d + ε + δ + γ ) ] ,

then

J ( P 0 ) = [ d β A d + α A + γ + δ 0 β A d + α A ( d + ε + γ + δ ) ] , det J ( P 0 ) = d ( d + ε + δ + γ ) ( 1 R 0 ) , tr J ( P 0 ) = d ( d + ε + δ + γ ) ( 1 R 0 ) .

Thus, P 0 ( A d ,0) is a stable node if R 0 <1, and is a saddle point if R 0 >1.

For P ( S , I ),

J ( P ) = [ d β I ( 1 + α S ) 2 β S 1 + α S + δ + γ β I ( 1 + α S ) 2 β S 1 + α S ( d + ε + δ + γ ) ] = [ d β I ( 1 + α S ) 2 ( d + ε ) β I ( 1 + α S ) 2 0 ] , tr J ( P ) = d β I ( 1 + α S ) 2 < 0 , det J ( P ) = ( d + ε ) β I ( 1 + α S ) 2 > 0 .

So, P ( S , I ) is a stable node if it exists.

The Jacobi matrix of model (1.3) is

J= [ d β I ( 1 + α S ) 2 β S 1 + α S + γ β I ( 1 + α S ) 2 β S 1 + α S ( d + ε + γ ) ] .

Then

detJ( P 1 )=dα [ α ( d + ε + γ ) β ] S 1 2 +2d [ α ( d + ε + γ ) β ] S 1 +d(d+ε+γ)+βA.

If β<α(d+ε+γ), P 1 ( S 1 , I 1 ) does not exist, then detJ( P 1 )>0.

Because

trJ( P 1 )= 1 ( 1 + α S 1 ) 2 [ β I 1 + β S 1 ( 1 + α S 1 ) ( 1 + α S 1 ) 2 ( 2 d + ε + γ ) ] <0,

then P 1 ( S 1 , I 1 ) is a stable node if it exists.

Consider points P 2 ( S 2 , I 2 ), P 3 ( S 3 , I 3 ),

J ( P 2 ) = [ d β I 2 ( 1 + α S 2 ) 2 β S 2 1 + α S 2 + γ β I 2 ( 1 + α S 2 ) 2 β S 2 1 + α S 2 ( d + ε + γ ) ] , tr ( P 2 ) = d β I 2 ( 1 + α S 2 ) 2 ( d + ε + γ ) + β S 2 1 + α S 2 tr ( P 2 ) = 1 ( 1 + α S 2 ) 2 ( d + ε ) [ β A + β d S 2 + β S 2 ( 1 + α S 2 ) ( d + ε ) tr ( P 2 ) = ( 1 + α S 2 ) 2 ( 2 d + ε + γ ) ( d + ε ) ] tr ( P 2 ) ( β ( d + ε ) S 2 + β α ( d + ε ) S 2 2 [ ( 2 d + ε + γ ) ( d + ε ) + 2 α ( 2 d + ε + γ ) ( d + ε ) S 2 tr ( P 2 ) = + ( 2 d + ε + γ ) ( d + ε ) α 2 S 2 2 ] ) / ( ( 1 + α S 2 ) 2 ( d + ε ) )

If β>α(d+ε+γ), then tr( P 2 )<0,

det J ( P 2 ) = d α [ α ( d + ε + γ ) β ] S 2 2 + 2 d [ α ( d + ε + γ ) β ] S 2 + d ( d + ε + γ ) + β A = d α [ α ( d + ε + γ ) β ] [ A ( d + ε ) I 2 ] 2 d 2 + 2 d [ α ( d + ε + γ ) β ] A ( d + ε ) I 2 d + d ( d + ε + γ ) + β A .

Because I 2 satisfies equation (2.6), we get

detJ( P 2 )= D 1 I 1 + D 2 = b Δ 2 2 ( d + α ) [ β α ( d + α + γ ) ] D 1 + D 2 ,

where

D 1 = α ( A α + d ) ( d + α + γ ) k α 2 ( d + α ) α β A D 1 = + 2 α ( d + α ) A + 2 d ( d + α ) [ β α ( d + α + γ ) ] , D 2 = α [ β α ( d + α + γ ) ] A 2 2 d [ β α ( d + α + γ ) ] A + d 2 ( d + α + γ ) + k ( A α + d ) .

If b Δ 2 2 ( d + α ) [ β α ( d + α + γ ) ] D 1 + D 2 >0, detJ( P 2 )>0 holds, then P 2 ( S 2 , I 2 ) is a stable node if β>α(d+ε+γ) and b Δ 2 2 ( d + α ) [ β α ( d + α + γ ) ] D 1 + D 2 >0. Similarly, P 3 ( S 3 , I 3 ) is a stable node if β>α(d+ε+γ) and b + Δ 2 2 ( d + α ) [ β α ( d + α + γ ) ] D 1 + D 2 >0. This completes the proof. □

Theorem 3.2 If δ<d, there is no limit cycle of model (1.1).

Proof Consider the Dulac function D= 1 I . Note that

P = A d S β S I 1 + α S + γ I + T ( I ) , Q = β S I 1 + α S ( d + ε + γ ) I T ( I ) .

If 0<I I 0 ,

( D P ) S + ( D Q ) I = d I β ( 1 + α S ) 2 <0.

If I> I 0 , because k=δ I 0 ,

( D P ) S + ( D Q ) I = d I β ( 1 + α S ) 2 + k I 2 = 1 I ( δ I 0 I d ) β ( 1 + α S ) 2 < 1 I (δd) β ( 1 + α S ) 2 .

Thus ( D P ) S + ( D Q ) I <0 if δ<d.

Then there is no limit cycle of model (1.1) if δ<d. This completes the proof. □

Theorem 3.3 There is no limit cycle of model (1.1) if βα(2d+ε+γ).

Proof If I I 0 , consider the Dulac function D= 1 I . Note that

P = A d S β S I 1 + α S + γ I + T ( I ) , Q = β S I 1 + α S ( d + ε + γ ) I T ( I ) , ( D P ) S + ( D Q ) I = d I β ( 1 + α S ) 2 < 0 .

If I> I 0 ,

( P ) S + ( Q ) I = d β I ( 1 + α S ) 2 + β S ( 1 + α S ) ( d + ε + γ ) ( P ) S + ( Q ) I = 1 ( 1 + α S ) 2 [ d ( 1 + α S ) 2 β I + β S ( 1 + α S ) ( d + ε + γ ) ( 1 + α S ) 2 ] ( P ) S + ( Q ) I = 1 ( 1 + α S ) 2 [ β I ( 2 d + ε + γ ) ( 1 + α S ) 2 + β S ( 1 + α S ) ] , ( 2 d + ε + γ ) ( 1 + α S ) 2 β S ( 1 + α S ) = ( 2 d + ε + γ ) ( 1 + α S ) β S = ( 2 d + ε + γ ) + α ( 2 d + ε + γ ) S β S .

Thus ( D P ) S + ( D Q ) I <0 if βα(2d+ε+γ).

Then there is no limit cycle of model (1.1) if βα(2d+ε+γ). This completes the proof. □

4 Numerical simulation and conclusion

With different A, d, γ, δ, ε, α, it is easy to test and verify the above results, so numerical simulation is omitted. In this paper, we study an SIS model with saturated incidence rate β S I 1 + α S and treatment. We get some relatively complex conclusions by stability theory and qualitative theory of differential equations. These conclusions will help policy makers to make decisions.

References

  1. 1.

    Jin Y, Wang W, Xiao S: An SIRS model with a nonlinear incidence rate. Chaos Solitons Fractals 2007, 34: 1482-1497. 10.1016/j.chaos.2006.04.022

    MathSciNet  Article  MATH  Google Scholar 

  2. 2.

    Cai L-M, Li X-Z: Analysis of a SEIV epidemic model with a nonlinear incidence rate. Appl. Math. Model. 2009, 33: 2919-2926. 10.1016/j.apm.2008.01.005

    MathSciNet  Article  MATH  Google Scholar 

  3. 3.

    Xu R, Ma Z: Stability of a delayed SIRS epidemic model with a nonlinear incidence rate. Chaos Solitons Fractals 2009, 41: 2319-2325. 10.1016/j.chaos.2008.09.007

    MathSciNet  Article  MATH  Google Scholar 

  4. 4.

    Wang X, Tao Y, Song X: Pulse vaccination on SEIR epidemic model with nonlinear incidence rate. Appl. Math. Comput. 2009, 210: 398-404. 10.1016/j.amc.2009.01.004

    MathSciNet  Article  MATH  Google Scholar 

  5. 5.

    Jiang Q, Wang J: Qualitative analysis of a harvested predator-prey system with Holling type III functional response. Adv. Differ. Equ. 2013., 2013: Article ID 249

    Google Scholar 

  6. 6.

    Wang J, Pan L: Qualitative analysis of a harvested predator-prey system with Holling-type III functional response incorporating a prey refuge. Adv. Differ. Equ. 2012., 2012: Article ID 96

    Google Scholar 

  7. 7.

    Wang J: Analysis of an SEIS epidemic model with a changing delitescence. Abstr. Appl. Anal. 2012., 2012: Article ID 318150 10.1155/2012/318150

    Google Scholar 

  8. 8.

    Zhang T, Teng Z: Global behavior and permanence of SIRS epidemic model with t time delay. Nonlinear Anal., Real World Appl. 2008, 9: 1409-1424. 10.1016/j.nonrwa.2007.03.010

    MathSciNet  Article  MATH  Google Scholar 

  9. 9.

    Mukhopadhyay B, Bhattacharyya R: Analysis of a spatially extended non-linear SEIS epidemic model with distinct incidence for exposed and infectives. Nonlinear Anal., Real World Appl. 2008, 9(2):585-598. 10.1016/j.nonrwa.2006.12.003

    MathSciNet  Article  MATH  Google Scholar 

  10. 10.

    Zhang J, Ma Z: Global dynamics of an SEIRS epidemic model with saturating contact rate. Math. Biosci. 2003, 185: 15-32. 10.1016/S0025-5564(03)00087-7

    MathSciNet  Article  MATH  Google Scholar 

  11. 11.

    Hethcote H, Ma Z, Liao S: Effects of quarantine in six endemic models for infectious diseases. Math. Biosci. 2002, 180: 141-160. 10.1016/S0025-5564(02)00111-6

    MathSciNet  Article  MATH  Google Scholar 

  12. 12.

    Martcheva M, Castillo-Chavez C: Diseases with chronic stage in a population with varying size. Math. Biosci. 2003, 182: 1-25. 10.1016/S0025-5564(02)00184-0

    MathSciNet  Article  MATH  Google Scholar 

  13. 13.

    Li X-Z, Li W-S, Ghosh M: Stability and bifurcation for an SIS epidemic model with treatment. Chaos Solitons Fractals 2009, 42: 2822-2832. 10.1016/j.chaos.2009.04.024

    MathSciNet  Article  MATH  Google Scholar 

Download references

Acknowledgements

The research was supported by the Fujian Nature Science Foundation under Grant No. 2014J01008.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jinghai Wang.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

The authors are entirely responsible for this research. The authors read and approved the final manuscript.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Jiang, Q. Analysis of an SIS epidemic model with treatment. Adv Differ Equ 2014, 246 (2014). https://doi.org/10.1186/1687-1847-2014-246

Download citation

Keywords

  • epidemic model
  • incidence rates
  • treatment
  • globally asymptotically stable